http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-112015027527-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5aff7364e15f7656fe18847ce1648808
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-381
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
filingDate 2014-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01237cc17e8699da3266a59617106051
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eda11f89eace916ee98afc7cec4f7ac2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62f6515928888d14a633ec2a1e9678f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_511c96b38d7a6ccabef6f92808b295e4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8e4733e3ce1c1f0eafb8937d6ac9639
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2bc287c648261eaf6e98634804776c4a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f398cf418109d7a2ffd38a25e7762e28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e5aa7bcb1302b312b2dbd1e8638ead2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_960b077816b517dfabab90778f88a2ac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5ad4bcd31328267c0af22bd966f9dd9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_997b9789e76394ecb80746552d171af0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fed78690838e0d4aa86f870a6656a245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d910e3e2af0b875cdc76f493e72fc609
publicationDate 2017-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-112015027527-A2
titleOfInvention counterpart zeste 2 inhibitor enhancer
abstract This invention relates to novel compounds according to formula (I), which are inhibitors of homologue zeste 2 enhancer (ezh2), to pharmaceutical compositions containing them, to processes for its preparation and its use in therapy for cancer treatment. (i)
priorityDate 2013-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452193847
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23676225

Total number of triples: 41.